Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Intangibles (2016 - 2025)

Conmed's Intangibles history spans 16 years, with the latest figure at $582.1 million for Q4 2025.

  • For Q4 2025, Intangibles fell 5.77% year-over-year to $582.1 million; the TTM value through Dec 2025 reached $582.1 million, down 5.77%, while the annual FY2025 figure was $582.1 million, 5.77% down from the prior year.
  • Intangibles reached $582.1 million in Q4 2025 per CNMD's latest filing, down from $593.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $689.5 million in Q3 2022 to a low of $463.4 million in Q1 2022.
  • Average Intangibles over 5 years is $591.7 million, with a median of $613.7 million recorded in 2024.
  • Peak YoY movement for Intangibles: dropped 6.17% in 2022, then soared 45.34% in 2023.
  • A 5-year view of Intangibles shows it stood at $471.0 million in 2021, then surged by 44.74% to $681.8 million in 2022, then fell by 4.74% to $649.5 million in 2023, then fell by 4.9% to $617.7 million in 2024, then dropped by 5.77% to $582.1 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Intangibles are $582.1 million (Q4 2025), $593.1 million (Q3 2025), and $601.8 million (Q2 2025).